Scholar Rock Holding (SRRK) Common Equity (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Common Equity came in at $276.0 million in Q1 2026, down 11.63% year-on-year from $312.3 million in Q1 2025, and up 12.43% quarter-over-quarter from $245.5 million in Q4 2025.

Scholar Rock Holding (SRRK) Common Equity (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Common Equity history runs 10 years deep, the most recent figure standing at $276.0 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 11.63% year-over-year to $276.0 million in Q1 2026; TTM through Mar 2026 was $276.0 million, a 11.63% decrease from a year earlier, with the FY2025 full-year figure at $245.5 million, down 33.41% from the prior year.
  • Common Equity improved to $276.0 million in Q1 2026 per SRRK's latest filing, from $245.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $368.6 million in Q4 2024 and bottomed at $79.2 million in Q3 2024.
  • The 5-year median for Common Equity is $233.3 million (2025), against an average of $232.6 million.
  • Across the five-year window, Common Equity slumped 52.77% in 2024 and surged 209.35% in 2025, its largest moves.
  • Year by year, Common Equity stood at $260.2 million in 2022, then dropped by 13.46% to $225.2 million in 2023, then surged by 63.68% to $368.6 million in 2024, then slumped by 33.41% to $245.5 million in 2025, then rose by 12.43% to $276.0 million in 2026.
  • Per Business Quant, the three latest SRRK Common Equity figures stand at $276.0 million (Q1 2026), $245.5 million (Q4 2025), and $245.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - 276.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 276.01 Mn
Dec 31, 2025 245.49 Mn
Sep 30, 2025 245.00 Mn
Jun 30, 2025 233.29 Mn
Mar 31, 2025 312.33 Mn
Dec 31, 2024 368.63 Mn
Sep 30, 2024 79.20 Mn
Jun 30, 2024 133.62 Mn
Mar 31, 2024 182.77 Mn
Dec 31, 2023 225.22 Mn
Sep 30, 2023 167.67 Mn
Jun 30, 2023 202.50 Mn
Mar 31, 2023 228.65 Mn
Dec 31, 2022 260.24 Mn
Sep 30, 2022 293.27 Mn
Jun 30, 2022 329.51 Mn
Mar 31, 2022 171.32 Mn
Dec 31, 2021 172.07 Mn
Sep 30, 2021 187.26 Mn
Jun 30, 2021 216.66 Mn